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Abstract: Hair loss is a disorder in which the hair falls out from skin areas such as the scalp and
the body. Several studies suggest the use of herbal medicine to treat related disorders, including
alopecia. Dermal microcirculation is essential for hair maintenance, and an insufficient blood supply
can lead to hair follicles (HF) diseases. This work aims to provide an insight into the ethnohistorical
records of some nutritional compounds containing flavonoids for their potential beneficial features in
repairing or recovering from hair follicle disruption. We started from a query for “alopecia” OR “hair
loss” AND “Panax ginseng C.A. Mey.“ (or other six botanicals) terms included in Pubmed and Web of
Sciences articles. The activities of seven common botanicals introduced with diet (Panax ginseng C.A.
Mey., Malus pumila Mill cultivar Annurca, Coffea arabica, Allium sativum L., Camellia sinensis (L.)
Kuntze, Rosmarinum officinalis L., Capsicum annum L.) are discussed, which are believed to reduce the
rate of hair loss or stimulate new hair growth. In this review, we pay our attention on the molecular
mechanisms underlying the bioactivity of the aforementioned nutritional compounds in vivo, ex vivo
and in vitro studies. There is a need for systematic evaluation of the most commonly used plants
to confirm their anti-hair loss power, identify possible mechanisms of action, and recommend their
best adoption.
Keywords: nutraceuticals; alopecia; flavonoids; Panax ginseng C.A. Mey.; Malus pumila Mill
cultivar Annurca; Caffeine; Allium sativum L.; Camellia sinensis (L.) Kuntze; Rosmarinum officinalis L.;
Capsicum annum L.
1. Introduction
Androgenic alopecia (AGA) is a common form of hair loss (HL), affecting men and women at
different ages [1,2]. In AGA, androgens are involved in the reduction of anagen phase, inducing an
increment of the number of hair follicles (HF) in the catagen and telogen phases as well as delaying the
telogen-to-anagen transition [3].
Generally, androgens affect several functions of the human skin, including sebaceous gland
proliferation and differentiation, hair growth (HG), and wound healing [4]. Though other hormones,
such as thyroid hormones and glucocorticoids, are involved in the process, androgens act as the master
players in human HG.
AGA is associated with high levels of dihydrotestosterone (DHT) released from testosterone by
the enzymatic activity of 5-alpha reductase (5α-R). DHT binds to the androgenic receptor (AR) to form
a hormone–receptor complex. DHT drastically reduces anagen phase, enhancing apoptosis of hair
cells, miniaturizing the HF, and causing HL [5]. The expression of both 5α-R and AR is enhanced in
patients with AGA [6].
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Androgens activity is also explained by in vitro experiments, where androgen stimulation of
scalp follicle dermal papilla cells (FDPC) triggers TGF-1 production [7]. The synthetic androgen R1881
suppresses keratinocyte growth in the co-culture of AR-overexpressing human FDPC obtained from
AGA and normal human keratinocytes through androgen-inducible TGF-1 [8,9]. As TGF-1 is known
to be a catagen inducer in hair cycling, it likely plays a role in the early catagen induction seen in
AGA [10]. Furthermore, TGF-2, the Wnt antagonist dickkopf-1, and IL-6 have been identified as
androgen-inducible negative regulators for AGA in in vitro experimental models [11,12].
Dermal microcirculation (DM) is essential for hair maintenance by delivering growth factors,
nutrients, cytokines, and other bioactive molecules, as well as by removing waste metabolic products.
DM is composed of a branching network of microvessels (<100 µm diameter) classified as arterioles,
venules, and capillaries [13]. DM has a remarkable capacity for adaptation to its cellular environment
and continuous interaction with the systemic circulation [13]. DM is essential for the maintaining
of skin homeostasis and includes different types of vessels, such as arterioles (from 17 to 26 µm in
diameter), meta-arterioles (10 to 20 µm), capillaries (8 to 10 µm), and venules [14].
The circulatory support during anagen phase suggests its association with the high metabolic
activity of HF matrix cells, and insufficient blood supply can lead to HF diseases [15]. Accordingly,
proangiogenic vascular endothelial growth factor (VEGF) regulates HG and follicle size [15].
Based on this mechanistic knowledge, several drugs have been formulated for the treatment of
alopecia over the last decade [1]. Here, we provide an overview of the currently available literature
devoted to alternative natural dietary treatments for HL (Figure 1). Among others, a recent work paid
attention to Mediterranean diet supporting the hypothesis that some fresh herbs and salad, rich in
phytochemicals such as carotenoids and polyphenols, may reduce the risk of AGA [16].
Figure 1. Schematic representation of hair follicle (HF) disruption. List of pharmacological drugs
approved by Food and Drug Administration (FDA) or natural interventions.
In the present review, we started for a query for “alopecia” OR “hair loss” AND
“Rosmarinum officinalis L.” (and other 6 botanicals) in ARTICLE (Title/Abstract/Keyword) in PUBMED
and Web of Sciences database.
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2. Results
2.1. Traditional Medical Treatments
Only two drugs are currently approved by the U.S. Food and Drug Administration (FDA) for the
treatment of AGA: Finasteride and Minoxidil (MXD) [17–19]. Finasteride is largely used as an oral
drug for the treatment of androgen-related hair disorders due to its inhibitory activity on 5α-R [18–20]
(Figure 2).
Of the two 5α-R human isoenzymes [19,20], type I predominates in the liver and skin including the
scalp [21,22], whereas type II is present in HF [23], as well as the prostate and genitourinary tract [22].
Finasteride was approved in 1997 at a dosage of 1 mg/day for use in adult men with mild-to-moderate
AGA. In addition to finasteride, a 5α-R2 inhibitor, a novel molecule called dutasteride has recently
been developed which is able to affect both 5α-R1 and 5α-R2. Oral dutasteride (0.5 mg/day) is another
option, but there are no studies that compare its efficacy to that of finasteride [24]. MXD was originally
developed as an antihypertensive agent, but attracted interest as a potential HL therapy; indeed,
patients treated with MXD developed generalized hypertrichosis [25]. MXD is a potassium channel
opener [17] and is used as topical application for male pattern baldness [9]. The mechanism of action of
MXD is not completely defined, but HG promotion is suggested to occur with an increased production
of several growth factors (i.e., IGF and VEGF), improving DM [17,25,26] (Figure 3). In vitro studies
of HG evidenced that hair cultures grown in the presence of MXD increase their viability, whereas
controls undergo necrosis.
2.2. Natural Alternative Interventions
Pharmacological approaches have their own side effects. For this reason, the medical attention
on HF disruption has been recently focused on the discovery of new and safer remedies, often
provided by natural therapies (e.g., Serenoa repens (SR) [27]. SR is an extract from the berries of
the saw palmetto palm tree (American dwarf tree) containing phytosterols (β-sitosterol), fatty acids,
β-carotene, and polysaccharides. SR acts as a competitive, nonselective inhibitor of both forms of
5α-R enzyme. The extract obtained from the berries of SR is rich in fatty acids (85–90%), and the other
constituents include sterols rich in carotenoids, lipases, tannin, sugars, and beta-sitosterol. In particular,
sitosterol and fatty acids are responsible for the inhibition of 5α-R [28]. Recently, we reported that
SR affects dermal endothelial cells’ permeability and tight junction proteins content in the paracrine
communication with follicle dermal papilla cells, providing a mechanistic background for its potential
use to promote HF vascularization [29].
The increasing use of natural dietary products is based on their ability to prompt hair growth (HG)
activity, to promote anagen phase, and to improve DM [30]. About this, recently, our laboratory tested
the effects of three flavonoids (visnadin (VSD), hesperidin (HSP), and baicalin (BC)), on primary human
dermal microvascular endothelial cells (HMVEC), comparing their effects with MXD. BC promoted
endothelial proliferation, while VSD and MXD enhanced angiogenic potential. Moreover, only HSP
increased VEGFR-2 phosphorylation [31].
Phenolic compounds and vitamins may give more specific support to the maintenance of HF
health [32]. Vitamin C improves blood vessel formation, increasing blood flow in the scalp by stimulating
VEGF synthesis [33]. Moreover, vitamin C potentiates the efficacy of therapeutic angiogenesis by cell
transplantation [34]. Vitamin D receptors are intracellular receptors expressed in HF cells, essential
for normal hair cycle and differentiation of the interfollicular epidermis. Homozygous knockout of
murine vitamin D receptor results in the development of alopecia and near-total HL at 8 months [35].
The lack of vitamin D receptor is associated with reduced epidermal differentiation and HF growth.
Deficiency of vitamin B7 (biotin) induces alopecia and other skin alterations such as dermatitis and
conjunctivitis. Accordingly, biotin supplementation is effective for HL in clinical trials [36]. In addition,
a large variety of amino acids has been considered for the treatment of HL. In particular, cystine and
lysine effects have been widely characterized in humans. Oral administration of L-cystine (70 mg)
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used in combination with retinol increases both hair density and anagen rate [37]. The combination of
L-cystine, histidine, and copper significantly increases the total hair count after 50 weeks in patients
with AGA [38]. In summary, L-cysteine plays a central role in the maintaining of hair health. Another
important amino acid characterized for its HG promotion properties is L-lysine, an essential amino acid
found in meat and eggs. In patients with chronic telogen affluvium, supplementation with L-lysine,
iron, vitamin B12, vitamin C, biotin, and selenium (Florisene®; Lambers Healthcare Ltd., Kent, UK)
resulted in a significant reduction of hair shedding after 6 months [39].
Figure 2. Finasteride action on Testosterone metabolism: block of 5-alpha reductase activity.
Figure 3. Schematic representation of Minoxidil (MXD) action on different cells of HF: keratinocytes,
dermal papilla cells and dermal microvascular endothelial cells. (1) MXD induces the release of
adenosine by follicle keratinocytes, (2) adenosine stimulates the release of growth factors (VEGF)
by follicle dermal papilla cells (FDPC), (3) VEGF promotes angiogenesis mechanism in dermal
microvascular endothelial cells.
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Polyphenolic phytochemicals also display several pharmacological properties and serve as a rich
reservoir for drug discovery. Currently, a limited number of studies reported the role of flavonoids in
patients with alopecia [40].
Silibinin, a secondary metabolite from Silybum marianum, is an effective antioxidant that prevents
various cutaneous problems. Recently, silibinin treatment was reported to enhance spheroid formation
of FDPC through the activation of AKT and Wnt/β-catenin-signaling pathways [41]. Another important
flavonoid widely used as traditional Chinese herbal medicine is BC. BC is commonly used for HL
treatment, but the precise molecular mechanism remains unknown. In mouse FDPC, BC stimulates
the expression of Wnt3a, Wnt5a, frizzled 7, and disheveled 2, whilst inhibiting the Axin/casein kinase
1α/adenomatous polyposis coli/glycogen synthase kinase 3β degradation complex and inducing the
Wnt/β-catenin-signaling activation. Moreover, BC increases the alkaline phosphatase levels in FDPC,
a process associated with the activation of Wnt pathway [42]. BC is mitogenic for human FDPC, where
it prevents nuclear translocation of the AR driven by DHT. These results suggest that BC could be used
as an active ingredient for treating androgen-related disorders, such as AGA [43].
Improvement of AGA was also observed after the topical application of Sophora flavescens
Aiton (Leguminosae) extract [44]. Sophora flavescens Aiton is a plant of traditional Chinese medicine.
A number of experimental observations have shown that Sophora flavescens root extract has vasodilatory,
antibacterial, antiandrogen, and antiulcer effects, making it a promising tool for an effective HL
treatment [44]. Sophora flavescens extract induces IGF-1 and FGF-7/KGF expression in cultured FDPC
and strongly inhibits 5α-R [45].
Prevention of alopecia areata (AA) was also observed after the treatment with quercetin. It may
be effective in both prevention and treatment for AA in the C3H/HeJ model, even if further clinical
studies are required [46].
In vivo studies evidenced that dietary supplementation with soy oil and soy-derived phytoestrogen
genistein significantly increases resistance to AA. Dietary soy oil content and soy-derived phytoestrogen
genistein increase resistance to AA onset in C3H/HeJ mice. The principal isoflavones in soy beans
are genistein (4′,5,7-trihydroxyisoflavone) and daidzein (4′,7-dihydroxyisoflavone). Soy oil content
can alter susceptibility to AA induced by skin grafting, with a potential key role for and soy-derived
genistein [47].
This work aims to provide an insight into the ethnohistorical records of some nutritional
compounds containing flavonoids for their potential beneficial features in repairing or recovering from
hair follicle disruption.
2.3. Botanicals Containing Flavonoids
Here, we consider seven natural compounds (Panax ginseng C.A. Mey., Malus pumila Mill. cultivar
Annurca, Coffea arabica L., Allium sativum L., Camellia sinensis (L.) Kuntze, Rosmarinum officinalis L.,
and Capsicum annum L.), containing flavonoids that are commonly introduced with diet and whose
in vivo, ex vivo, and in vitro biological activities are reported by recent specialized literature.
2.3.1. Panax ginseng C.A. Mey.
Panax ginseng C.A. Mey. is a traditional Chinese remedy well-known worldwide and known by the
popular name ginseng. The three key ingredients of ginseng are saponins, polysaccharides, and phenolic
compounds [48]. Saponins are recognized as primary pharmacologically active components [49].
Ginsenoside (is the alternative name of saponins) are categorized into two different groups, based on
their chemical structure, known as oleanane type (five ring structure) and dammarane type (four ring
structure). Ginseng contains two types of polysaccharides: one of them is composed of starch like glucan
known as neutral polysaccharide, and the other is an acidic polysaccharide [50]. Acidic polysaccharide
has enhanced antitumor and antioxidant properties as compared with neutral polysaccharides [50].
Ginseng also contains non-water-soluble polyacetylenes such as the panoxynol-polyacetylene [50].
Polyacetylenes do show effects against cancerous cells, but in vivo there is no proven fact presently
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owing to their chemical nature [51]. Recently, research has demonstrated that ginseng acts as a
chemo-preventive agent owing to its anticancer properties. In general, red ginseng oil (RGO) exerts
anti-inflammatory [50], antioxidant, and hepato-protective activities [50]. The wild-growing or
cultivated ginseng root, which is collected in the fall, is officially listed in the Chinese Pharmacopoeia
and is used as a tonic. Panax ginseng C.A. Mey. has been revealed to promote HG [52–54]. Treatment
of mice with RGO upregulates Wnt/β-catenin and Shh/Gli-pathways-mediated expression of genes
such as β-catenin, Lef-1, sonic hedgehog, Cyclin D1, and Cyclin E [55]. In addition, RGO and its major
components downregulate TGF-β [56–58] and enhance antiapoptotic protein Bcl-2 expression [55].
Matsuda H. et al., (2003) reported the promotion of HG by ginseng radix on cultured mouse vibrissal
HF [59]. Korean red ginseng (KRG), in combination with topical MXD, is more effective than MXD
for the promotion of HG in human clinical studies [60]. Ginsenoside is able to increase the hair shaft
length and hair existent time, which is similar to the action of MXD in in vivo experimental models
(topical treatment in nude mice), moreover, it stimulates hair shaft elongation in ex vivo cultures of
vibrissa HF and suppresses TGF-β-induced phosphorylation of ERK in HeLa cells [61]. It also promotes
the proliferation of human dermal follicle papilla cells and keratinocytes and enhances hair anagen
induction or acceleration of HG in mouse [61] (See Table 1). In chemotherapy-induced alopecia, KRG
protects against premature catagen development through modulation of p53 and Bax/Bcl2 expression.
Finally, ginseng exerts mitogenic and antiapoptotic effects in outer root sheath keratinocytes [62,63].
Table 1. Schematic representation of in vitro cellular models used to test the role of Panax ginseng
C.A. Mey.
Panax ginseng C.A. Mey In VitroCellular Models Authors and Year Results
Deciduous perennial plant belonging to the
Araliaceae family.
Clinically used as a herbal medicine for
several millennia in East Asia.
Human dermal follicle
papilla cells
and keratinocytes
First Author: Shin
Year: 2014 Proliferation
Outer root sheath
keratinocytes
Antiapoptotic
effects
2.3.2. Malus pumila Mill. cultivar Annurca
Malus pumila Mill. cultivar Annurca (Annurca apple), a native of Southern Italy, displays higher
content of oligomeric procyanidins, such as procyanidin B2, compared with more common apple
samples including Red Delicious, Granny Smith, Pink Lady, Fuji, and Golden Delicious [64,65].
In general, apples are the most deeply studied and consumed fruits in northern Europe and North
America. Phytochemical studies have shown that apple contains various components including
polysaccharides, tri-terpenoids, phytosterols, phenols, and other components such as protein [66],
vitamins (A, C, and E), α-carotene, and metal elements (i.e., iron, magnesium, calcium, zinc, manganese,
sulfur, copper, and potassium) essential for human health [66]. Apples also contain different polyphenols
in different tissues. In particular, variety and contents of polyphenols in apple peel are relatively high,
although there are different polyphenols in apple: phenolic acid and flavonoids are reported to be the
most important constituents [66] (see Table 2).
Table 2. Schematic representation of in vitro cellular models used to test the effects of Malus pumila
Mill cultivar Annurca.
Malus Pumila Mill Cultivar Annurca In VitroCellular Models Authors and Year Results
Cultivated in Southern Italy with a Protected
Geographical Indication of the Campania region [65].
nontumorigenic human
keratinocytes
First Author: Tenore
Year: 2018
Increased cell
survival and
keratin expression.
Clinical trials provide strong evidence supporting the ability of procyanidin B2 contained in
Annurca apple extract to improve HG and skin quality, as well as to increase hair density, weight,
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and keratin content [67]. Procyanidin B2 acts on keratin biosynthesis in a nontumorigenic human
keratinocyte cell line, suggesting its nutraceutical power on human HG and tropism [66,67]. Polyphenols
of Annurca apple regulate murine HF metabolism, inhibiting several NADPH-dependent reactions
and stimulating mitochondrial respiration, β-oxidation, and keratin production [66,67] (see Table 2).
The same components protect murine HF from taxane-induced alopecia, a common side effect of
conventional chemotherapy [68].
2.3.3. Allium sativum L.
Allium sativum L. (garlic) originates from central Asia (over 6000 years ago) and has long been a
staple food in the Mediterranean region, as well as a frequent seasoning in Europe and Africa [69].
Moreover, it represents a part of the daily diet for most of the human population. Fresh garlic contains
water, fiber, lipids, proteins, carbohydrates (such as fructose), vitamins (mainly C and A), minerals
(such as potassium, phosphorus, magnesium, sodium, iron, and calcium), phytosterols, and phenolic
derivatives, as well as organic sulfur compounds. On the basis of solubility, its chemical composition
can be divided into two large groups: 1) compounds of lipid-soluble allyl sulfur (such as diallyl sulfur
(DAS), diallyl disulfide (DADS), and diallyl trisulfide (DATS)) and 2) water-soluble compounds, such as
of g-glutamyl S-allylcysteine (SAC) and S-allyllmercaptocysteine (SAMC) [70,71]. Allium sativum L.
has been widely used throughout history for its prophylactic and therapeutic effects. It is still used
in folk medicine all over the world to treat several diseases [72]. Allium sativum L. is widely known
for its biological properties and plays an important role as an antioxidant [73]. Allium sativum L.
modulates lipid metabolism, and its consumption is associated with lowering blood cholesterol
levels. Allium sativum L. exerts a significant effect on the cardiovascular system where it reduces
blood pressure, inhibits platelet aggregation, and exerts antioxidant and fibrinolytic activities [73].
Moreover, Allium sativum L. significantly decreases HMG-CoA reductase activity and may have an
effect on the level of cholesterol hydroxylase and other enzymes. Its oral administration is effective
on DM [74]; in particular, a randomized placebo-controlled, double-blinded study demonstrated that
administration of Allium sativum L. powder for 5 h significantly improves capillary skin perfusion in
55% of healthy volunteers [74]. Allium sativum L. is also involved in protection from photodamage
and cellular senescence in UVB-exposed human keratinocytes [75] (Table 3). Allium sativum L. was
recently considered among herbal medicines for clinical research in the field of AA treatment [76].
In a double-blinded, randomized controlled trial of subjects affected by AA, garlic gel significantly
increased the therapeutic efficacy of topical betamethasone [77].
Table 3. Schematic representation of in vitro cellular models used to test the role of Allium sativum L.
Allium sativum L. In VitroCellular Models Authors and Year Results
Cultivated worldwide for use as a spice and
for its medicinal properties. Human keratinocytes.
First Author: Kim
Year: 2016
Protection against
UVB damage.
2.3.4. Coffea arabica L.
Caffeine from Coffea arabica L. is a xanthine (purine) alkaloid also found in Paullinia cupana Kunth
(Guarana), Ilex paraguariensis A.St.-Hil. (yerba maté), Cacao minar Gaertn. (Cacao), and several species
used to make tea [78]. The type of caffeine is strictly related to the social habits and the culture of
regions [78]. In green coffee, the largest lipid fraction occurs in the oil of the bean endosperm. There
is also a small amount of wax in the outer layers of the bean. Coffee oil consists of triacylglycerols,
phospholipids, sterols, tocopherols, and diterpenes [79]. Caffeine effects are mainly mediated by the
inhibition of phosphodiesterase, which causes an increased intracellular adenylate cyclase activity,
enhancing the cyclic 3′,5′-adenosine monophosphate (cAMP) levels, therefore providing higher energy
levels to promote increased metabolic activity and cell proliferation. Coffee has been studied for a
long time in relation to its cultural and social impact, and some of its components have been isolated.
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Products containing caffeine are promising tools for potential treatments for AGA both in vitro and
in vivo models. In ex-vivo models, they stimulate human HG of HF obtained from patients affected
by AGA [80]. Specifically, a work by Fisher et al. (2007) showed caffeine enhancement of hair shaft
elongation, prolonging anagen duration and hair matrix keratinocyte proliferation; moreover, female
HFs show a higher sensitivity to caffeine than male HFs [80]. Caffeine counteracts testosterone-enhanced
TGF-2 protein expression in male HFs and reduces TGF-2 expression in female HFs, while it enhances
intrafollicular IGF-1 protein expression in both sexes [80]. Accordingly, it enhances hair shaft elongation,
prolongs anagen duration, and promotes the proliferation of hair matrix keratinocytes [81] (Table 4).
In men affected by AGA, topical application of caffeine may be considered more effective than MXD 5%
topical solution [82]. In female subjects, shampoo containing caffeine significantly prevents HL [82].
Table 4. Schematic representation of in vitro cellular models used to test the role of Coffea arabica L.
Coffea arabica L. Cellular Models Authors and Year Results
Caffeine is widely consumed in foods and beverages and is
also used for a variety of medical purposes.
Caffeine is a xanthine (purine) alkaloid found in guarana,
yerba maté, cacao, and several species used to make tea.
Hair
matrix keratinocytes
First Author:
Bussoletti
Year: 2018
Proliferation
2.3.5. Camellia sinensis (L.) Kuntze
Camellia sinensis (L.) Kuntze, is an evergreen, perennial plant, including cross-pollinated tree
species native to China and Southeast Asia, very important for human well-being [83]. Tea, a product
of the plant Camellia sinensis (L.) Kuntze, is one of the most consumed beverages in the world.
Green, black, and oolong teas are made from the same plant but are processed differently, depending
on their degree of fermentation [84]. Several human observational and intervention studies have
found beneficial effects of tea consumption on neurodegenerative impairment, such as cognitive
dysfunction and memory loss [83]. Actually, some reports have demonstrated that catechins are
the major components in leaves that acted as agonists of the nuclear receptor protein peroxisome
proliferator-activated receptor gamma (PPAR-c); therefore, they could be considered as current
pharmacological targets for the treatment of type 2 diabetes mellitus (T2DM) [85]. The rich saponins and
catechins in Camellia sinensis (L.) Kuntze seeds have been known to lower body weight and serum lipid
levels [86,87]. Camellia sinensis (L.) Kuntze leaves contain catechins, such as epigallocatechin-3-gallate,
as well as quercetin, the aflavins, the arubigins, the anine, caffeine, chlorogenic acid, and gallic acid.
Its beneficial anticancer and antioxidant effects are mediated by epigallocatechin-3-gallate (EGCG),
the major constituent of polyphenols [87,88]. p38 and JNK-MAPK pathways are essential for EGCG
induction of p57 and caspase 14 in keratinocytes, reducing psoriasiform lesions in the flaky skin mouse
model [89] (see Table 5). Recently, EGCG was proposed for the prevention or treatment of AGA by
selectively inhibiting 5α-R activity [90]. It reveals as a potent inhibitor in cell-free environment but not
in whole-cell assays of 5α-R. Replacement of the gallate ester in EGCG with long-chain fatty acids
produced potent 5α-R inhibitors that were active in both cell-free and whole-cell assay systems [90].
EGCG stimulates human HG via its proliferative and antiapoptotic effects on FDPC and may prolong
anagen stage [91]
Table 5. Schematic representation of in vitro cellular models used to test the role of Camellia
sinensis (L.) Kuntze.
Camellia sinensis (L.) kuntze Cellular Models Authors and Year Results
Is a nonfermented product, obtained by harvesting fresh
leaves, and is the most common in the Far East, where its
consumption has very strong traditional and historical roots.
Keratinocytes First Author: HsuYear: 2007
Induction of p57 and
caspase 14.
Follicle dermal
papilla cells
First Author: Kwon
Year: 2007 Antiapoptotic effects
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2.3.6. Rosmarinus officinalis L.
Rosmarinus officinalis L. (RO) is a common evergreen, aromatic shrub that grows in several areas
of the world. RO is known for its nutritional values and pharmacological properties that made it
renowned in traditional medicine [92,93]. RO extract significantly prevents food deterioration when
added to products such as dairy products, meat, fish, oil dressing, and frying oil; moreover, it shows
better efficiency than conventional preservatives [94]. The main active compounds responsible for
these functions in RO are carnosic acid (CaA), carnosol, and rosmarinic acid [95]. Although CaA
has the most potent antioxidant and antimicrobial activity among these active compounds [94–96],
its deployment in water-based food systems is limited by its low solubility [97]. RO is used in cosmetic
products and displays different properties, including enhancement of microcapillary perfusion [97].
Indeed, in the study by Panahi et al. (2015), patients with AGA were randomly assigned to rosemary
oil or MXD 2% for 6 months, and the results obtained evidenced no significant change in the mean
hair count at the 3 month endpoint, neither in the RO nor in the MXD group. Conversely, the authors
reported that both groups reported a significant increase in hair count at the 6 month endpoint [97].
In the work of Borrás-Linares (2014), it was reported that an improvement of blood circulation
and vascularity induced by RO helps the regeneration of HF similarly to MXD [98]. A randomized
comparative trial provided evidence for RO efficacy in the treatment of AGA [97]. Topical administration
of RO leaf extract (2 mg/day/mouse) improved HG when topically administrated to C57BL/6NCrSlc
mice [99] and promoted prostate cancer cell line LNCaP proliferation in in vitro models. Moreover, RO
leaf extract showed inhibitory activity on testosterone 5α-R [99] (Table 6).
Table 6. Schematic representation of in vitro cellular models used to test the role of Rosmarinus
officinalis L.
Rosmarinus officinalis L. Cellular Models Authors and Year Results
An evergreen perennial shrub native to Europe and cultivated in many parts of
the world, rosemary leaves are used as spices and flavoring agents because of the
desirable flavor and antioxidant activity.
Prostate cancer cell
line LNCaP.
First Author: Murata
Year: 2013 Proliferation
2.3.7. Capsicum annum L.
Capsicum annuum L. originated in the area bordered by the mountains of Southern Brazil, Bolivia,
Northern Argentina, and Paraguay [100]. It is one of the major vegetable and spice crops cultivated
worldwide for its nutritional value and spicy nature.
In addition to their sensory features, such as pungency, aroma, and color, peppers are important
sources of bioactive compounds, such as vitamins (C and E, provitamin A) and phenols compounds.
The content of these phytochemicals changes with the metabolic and chemical processes; therefore,
sampling and storage conditions (i.e., T ◦C <7.5 ◦C, oxygen depletion, absence of light, or ∼70% relative
humidity) may be controlled in order to produce a high-quality plant material for its characterization
and further use [101]. The amount of bioactive compounds is associated with the fruit part (placenta,
pericarp, and seeds), the cultivar or variety, the ripening stage, the climatic and storage conditions,
as well as the processing practices [102]. Carotenoids are usually the major phytochemicals found in
pepper varieties, which add high commercial value to these fruits in terms of color and antioxidant
properties and flavor characteristics, among other bioactivities. Capsaicinoids are mainly found in
hot peppers and are responsible for the pungency of these varieties. Peppers are also rich in phenolic
compounds, such as flavonoids and phenolic acid derivatives, as well as vitamins (A and C) and
minerals (i.e., iron, calcium, and manganese), highly contributing human nutrition [103].
Experimental observations strongly suggest that the combination of capsaicin and isoflavone, two
bioactive compounds included in the crop, significantly increase IGF-I production in HF, promoting
HG [103,104]. In particular, capsaicin binds to transient receptor potential cation channel subfamily V
member 1 (TRPV1), also known as the vanilloid receptor 1, increasing the release of calcitonin peptide
(CGRP) from sensory neurons and finally raising IGF-I production [105]. Intradermal injection of
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capsaicin induces anagen phase in mice [105]. A new antibaldness agent based on Interconnected
PolymerS TeChnology is an effective strategy for the delivery of bioactive molecules such as Origanum
vulgare leaf extract, Camellia sinensis leaf extract, and Capsicum annuum fruit extract, and their
combined activities are mediated by sensory neuron activation in the skin [106] (Table 7).
Table 7. Schematic representation of in vitro cellular models used to test the role of Capsicum annum L.
Capsicum annum L. Cellular Models Authors and Year Results
Used in Tunisian culinary preparations, which make them one
of the most important cultivated vegetables.
Androgen-dependent
prostate cancer cells
(LNCaP).
Human monocytic
leukemia cell line THP-1.
First Author: Parisi
Year: 2018
Cell viability and
5-alpha
reductase activity
When capsaicin was injected intradermally in C57BL/6 mice with all follicles in the telogen phase
of HF cycle, it induced significant hair growth (anagen) in the back skin of telogen mice, which was
associated with substantial mast cell degranulation [107].
3. Discussion
HG is a cyclically controlled process formed by three distinct phases in mammals, respectively
called anagen (growing phase), catagen (regressing phase), and telogen (resting phase). During
catagen, HF regression is a tightly coordinated process characterized by apoptosis and terminal
differentiation of the proximal epithelial HF, perifollicular proteolysis, and matrix remodeling [108,109].
The development of HG is influenced by a variety of growth factors and cytokines, as well as the
keratinocyte growth factors interleukin-1 and TGF-β [107].
HL is a symptom of a variety of several forms of alopecia, including AGA, AA, and telogen
effluvium [110]. Recognized treatment involves the use of drugs that are effective only upon continued
administration and are not free from side effects [110–113]. Some patients may find MXD use unhandy
or expensive. Moreover, potential cardiovascular side effects may discourage its prescription for
the treatment of HL by dermatologists [114,115]. In relation to finasteride, controversy surrounding
potential adverse sexual side effects has negatively affected its public perception and may drastically
reduce the number of patients who can profit from this drug.
Therefore, there is a need for alternative treatments, including physical or cosmetic treatments,
supplements, and the use of herbal extracts [116,117].
The state of the art in the current treatment of HF diseases is the result of recent advances in its
etiology and progression. Androgen antagonism, angiogenesis modulation, vasodilation through
potassium channel opening, as well as 5-R inhibition, are the major nonsurgical pharmacological
strategies employed until today [17,18]. On the other hand, the broad availability and lower costs of
unconventional remedies based on the use of natural compounds has encouraged deeper investigation
of their features [118,119].
Moreover, recent studies evidenced that autologous regenerative therapies such as the treatments
with platelet-rich plasma (PRP), autologous growth factors, or Adipose-derived human follicle stem
cells (HFSCs) are successfully used to promote hair regrowth [120,121]. Specifically, it was evidenced
that PRP injections on male subjects significantly prevented HL without major side effects. Moreover,
the use of autologous cell biological technique (A-CBT) based on micrografts infusions on AGA
patients promoted HG [120,121]. In this context, a relevant role is played by Wnt-α-catenin-signaling
pathway; specifically, the increment of Wnt signaling in FDPCs is one of the principal factors that
enhanced HG [120,121]. Recent works reported the role of some natural compounds on the activation
of Wnt-α-catenin signaling in the promotion of HG [122].
In the present review, we summarized the activities of seven common botanicals introduced with
diet (Panax ginseng C.A. Mey., Malus pumila Mill cultivar Annurca, Coffee arabica L., Allium sativum L.,
Camellia sinensis (L.) Kuntze, Rosmarinum officinalis L., Capsicum annum L.), particularly promising
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for their ability to reduce the rate of HL or stimulate HG. Their effects reported in a huge literature
are discussed, with the limitations including the known gap occurring among different experimental
strategies—in vitro, ex vivo, in vivo, and clinical trials—which makes integrative mechanistic
explanations quite difficult.
Author Contributions: Conceptualization, E.B.; writing—original draft preparation; E.B.; writing—review and
editing, E.B., L.M., and F.G. All authors have read and agree to the published version of the manuscript.
Funding: This research received no external funding.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Kelly, Y.; Blanco, A.; Tosti, A. Androgenetic Alopecia: An Update of Treatment Options. Drugs 2016, 76,
1349–1364. [CrossRef]
2. Hoffmann, R. Male androgenetic alopecia. Clin. Exp. Dermatol. 2002, 27, 373–382. [CrossRef]
3. Buhl, A.E.; Conrad, S.J.; Waldon, D.J.; Brunden, M.N. Potassium channel conductance as a control mechanism
in hair follicles. J. Investig. Dermatol. 1993, 101, 148S–152S. [CrossRef]
4. Price, V.H. Androgenetic alopecia in women. J. Investig. Dermatol. Symp. Proc. 2003, 8, 24–27. [CrossRef]
5. Sawaya, M.E.; Price, V.H. Different levels of 5alpha-reductase type I and II, aromatase, and androgen receptor
in hair follicles of women and men with androgenetic alopecia. J. Investig. Dermatol. 1997, 109, 296–300.
[CrossRef]
6. Schmidt-Ullrich and Paus. Review. Molecular principles of hair follicle induction and morphogenesis.
Bioessays 2005, 27, 247–261. [CrossRef] [PubMed]
7. Inui, S.; Fukuzato, Y.; Nakajima, T.; Yoshikawa, K.; Itami, S. Identification of androgen-inducible TGF-beta1
derived from dermal papilla cells as a key mediator in androgenetic alopecia. J. Investig. Dermatol. Symp. Proc.
2003, 8, 69–71. [CrossRef] [PubMed]
8. Inui, S.; Fukuzato, Y.; Nakajima, T.; Yoshikawa, K.; Itami, S. Androgen-inducible TGF-beta1 from balding
dermal papilla cells inhibits epithelial cell growth: A clue to understand paradoxical effects of androgen on
human hair growth. FASEB J. 2002, 16, 1967–1969. [CrossRef] [PubMed]
9. Inui, S.; Itami, S. Molecular basis of androgenetic alopecia: From androgen to paracrine mediators through
dermal papilla. J. Dermatol. Sci. 2011, 61, 1–6. [CrossRef]
10. Hibino, T.; Nishiyama, T. Role of TGF-beta2 in the human hair cycle. J. Dermatol. Sci. 2004, 35, 9–18.
[CrossRef] [PubMed]
11. Kwack, M.H.; Sung, Y.K.; Chung, E.J.; Im, S.U.; Ahn, J.S.; Kim, M.K.; Kim, J.C. Dihydrotestosterone-inducible
dickkopf 1 frombalding dermal papilla cells causes apoptosis in follicular kera-tinocytes. J. Investig. Dermatol.
2008, 128, 262–269. [CrossRef] [PubMed]
12. Kwack, M.H.; Ahn, J.S.; Kim, M.K.; Kim, J.C.; Sung, Y.K. Dihydrotestosterone-inducible IL-6 inhibits
elongation of humanhair shafts by suppressing matrix cell proliferation and promotesregression of hair
follicles in mice. J. Investig. Dermatol. 2012, 132, 43–49. [CrossRef] [PubMed]
13. Ocak, I.; Kara, A.; Ince, C. Monitoring microcirculation. Best Pract. Res. Clin. Anaesthesiol. 2016, 30, 407–418.
[CrossRef] [PubMed]
14. Deegan, A.J.; Wang, R.K. Microvascular imaging of the skin. Phys. Med. Biol. 2019, 64, 07TR01. [CrossRef]
[PubMed]
15. Yano, K.; Brown, L.F.; Detmar, M. Thrombospondin-1 plays a critical role in the induction of hair follicle
involution and vascular regression during the catagen phase. J. Investig. Dermatol. 2003, 120, 14–19.
[CrossRef] [PubMed]
16. Fortes, C.; Mastroeni, S.; Mannooranparampil, T.; Abeni, D.; Panebianco, A. Mediterranean diet: Fresh herbs
and fresh vegetables decrease the risk of Androgenetic Alopecia in males. Arch. Dermatol. Res. 2018, 310,
71–76. [CrossRef]
17. Messenger, A.G.; Rundegren, J. Minoxidil: Mechanisms of action on hair growth. Br. J. Dermatol. 2004, 150,
186–194. [CrossRef]
Int. J. Mol. Sci. 2020, 21, 523 12 of 17
18. Kaufman, K.D.; Olsen, E.A.; Whiting, D.; Savin, R.; DeVillez, R.; Bergfeld, W.; Price, V.H.; Van Neste, D.;
Roberts, J.L.; Hordinsky, M.; et al. Finasteride in the treatment of men with androgenetic alopecia. Finasteride
Male Pattern Hair Loss Study Group. J. Am. Acad. Dermatol. 1998, 39, 578–589. [CrossRef]
19. Harris, G.; Azzolina, B.; Baginsky, W.; Cimis, G.; Rasmus-son, H.; Tolman, R.L.; Raetz, C.R.; Ellsworth, K.
Identfication andselective inhibition of an isozyme of steroid 5 alpha-reductase inhuman scalp. Proc. Natl.
Acad. Sci. USA 1992, 89, 10787–10791. [CrossRef]
20. Russell, D.W.; Wilson, J.D. Steroid 5 alpha-reductase: Two genes/two enzymes. Annu. Rev. Biochem. 1994, 63,
25–61. [CrossRef]
21. Thigpen, A.E.; Silver, R.I.; Guileyardo, J.M.; Casey, M.L.; McConnell, J.D.; Russell, D.W. Tissue distribution
and ontogeny ofsteroid 5 alpha-reductase isozyme expression. J. Clin. Investig. 1993, 1993. 92, 903–910.
[CrossRef]
22. Bayne, E.; Flanagan, J.; Azzolina, B.; Einstein, R.; Mumford, J.; Avala, B.; Chang, D.; Thiboutot, I.; Singer, I.;
Harris, G. Immunolo-calization of type 2 5a-reductase in human hair follicles. J. Investig. Dermatol. 1997,
4, 651.
23. Drake, L.; Hordinsky, M.; Fiedler, V.; Swinehart, J.; Unger, W.P.; Cotterill, P.C.; Thiboutot, D.M.; Lowe, N.;
Jacobson, C.; Whiting, D.; et al. The effects offinasteride on scalp skin and serum androgenlevels in men with
androgenetic alopecia. J. Am. Acad. Dermatol. 1999, 41, 550–554. [PubMed]
24. Zhou, Z.; Song, S.; Gao, Z.; Wu, J.; Ma, J.; Cui, Y. The efficacy and safety of dutasteride compared
with finasteride in treating men with androgenetic alopecia: A systematic review and meta-analysis.
Clin. Interv. Aging 2019, 20, 399–406. [CrossRef] [PubMed]
25. Chellini, P.R.; Pirmez, R.; Raso, P.; Sodré, C.T. Generalized Hypertrichosis Induced by Topical Minoxidil in
an Adult Woman. Int. J. Trichol. 2015, 7, 182–183. [CrossRef] [PubMed]
26. Cotsarelis, G.; Millar, S.E. Towards a molecular understanding of hair loss and its treatment. Trends Mol. Med.
2001, 7, 293–301. [CrossRef]
27. Murugusundram, S. Serenoa Repens: Does It have Any Role in the Management of Androgenetic Alopecia?
J. Cutan. Aesthet. Surg. 2009, 2, 31–32. [CrossRef]
28. Rossi, A.; Mari, E.; Scarnò, M.; Garelli, V.; Maxia, C.; Scali, E.; Iorio, A.; Carlesimo, M. Comparitive
effectiveness of finasteride vs. Serenoa repens in male androgenetic alopecia: A two-year study. Int. J.
Immunopathol. Pharmacol. 2012, 25, 1167–1173. [CrossRef]
29. Bassino, E.; Gasparri, F.; Munaron, L. Serenoa repens and N-acetyl glucosamine/milk proteins complex
differentially affect the paracrine communication between endothelial and follicle dermal papilla cells.
J. Cell. Physiol. 2019, 234, 7320–7329. [CrossRef]
30. Bassino, E.; Antoniotti, S.; Gasparri, F.; Munaron, L. Effects of flavonoid derivatives on human microvascular
endothelial cells. Nat. Prod. Res. 2016, 30, 2831–2834. [CrossRef]
31. Bassino, E.; Gasparri, F.; Munaron, L. Natural dietary antioxidants containing flavonoids modulate
keratinocytes physiology: In vitro tri-culture models. J. Ethnopharmacol. 2019, 238, 111844. [CrossRef]
[PubMed]
32. Działo, M.; Mierziak, J.; Korzun, U.; Preisner, M.; Szopa, J.; Kulma, A. The Potential of Plant Phenolics in
Prevention andTherapy of Skin Disorders. Int. J. Mol. Sci. 2016, 17, 160. [CrossRef] [PubMed]
33. Semalty, M.; Semalty, A.; Joshi, G.P.; Rawat, M.S. Hair growth and rejuvenation: An overview. J. Dermatol. Treat.
2011, 22, 123–132. [CrossRef] [PubMed]
34. Takeshita, Y.; Katsuki, Y.; Katsuda, Y.; Kai, H.; Saito, Y.; Arima, K. Vitamin C reversed malfunction of
peripheral blood-derived mononuclear cells in smok-ers through antioxidant properties. Circ. J. 2008, 72,
654–659. [CrossRef]
35. Xie, Z.; Komuves, L.; Yu, Q.-C.; Elalieh, H.; Ng, D.C.; Leary, C.; Chang, S.; Crumrine, D.; Bikle, D.D.;
Yoshizawa, T.; et al. Lack of the vitamin D receptor is associated with reduced epidermal differentiation and
hair follicle growth. J. Investig. Dermatol. 2002, 118, 11–16. [CrossRef]
36. Zempleni, J.; Hassan, Y.I.; Wijeratne, S.S. Biotin and biotinidase deficiency. Expert. Rev. Endocrinol. Metab.
2008, 3, 715–724. [CrossRef]
37. Hertel, H.; Gollnick, H.; Matthies, C.; Baumann, I.; Orfanos, C.E. Low dosage retinol and L-cystine
combination improve alopecia of the diffuse type following long-term oral administration. Hautarzt. 1989,
40, 490–495.
Int. J. Mol. Sci. 2020, 21, 523 13 of 17
38. Morganti, P.; Fabrizi, P.; James, B.; Bruno, C. Effect of gelatin-cystine and Serenoa repens extract on free
radicals level and hair growth. J. Appl. Cosmetol. 1998, 16, 57–64.
39. Rushton, D.H.; Norris, M.J.; Dover, R.; Busuttil, N. Causes of hair loss and the developments in hair
rejuvenation. Int. J. Cosmet. Sci. 2002, 24, 17–23. [CrossRef]
40. Tuong, W.; Walker, L.; Sivamani, R.K. Polyphenols as novel treatment options for dermatological diseases:
A systematic review of clinical trials. J. Dermatol. Treat. 2015, 26, 381–388. [CrossRef]
41. Cheon, H.I.; Bae, S.; Ahn, K.J. Flavonoid Silibinin Increases Hair-Inductive Property Via Akt and
Wnt/β-Catenin Signaling Activation in 3-Dimensional-Spheroid Cultured Human Dermal Papilla Cells.
J. Microbiol. Biotechnol. 2019, 29, 321–329. [CrossRef] [PubMed]
42. Xing, F.; Yi, W.J.; Miao, F.; Su, M.Y.; Lei, T.C. Baicalin increases hair follicle development by increasing
canonical Wnt/β-catenin signaling and activating dermal papillar cells in mice. Int. J. Mol. Med. 2018, 41,
2079–2085. [CrossRef] [PubMed]
43. Kim, A.R.; Kim, S.N.; Jung, I.K.; Kim, H.H.; Park, Y.H.; Park, W.S. The inhibitory effect of Scutellaria
baicalensis extract and its active compound, baicalin, on the translocation of the androgen receptor with
implications for preventing androgenetic alopecia. Planta. Med. 2014, 80, 153–158. [CrossRef] [PubMed]
44. Takahashi, T.; Ishino, A.; Arai, T.; Hamada, C.; Nakazawa, Y.; Iwabuchi, T.; Tajima, M. Improvement of
androgenetic alopecia with topical Sophora flavescens Aiton extract, and identification of the two active
compounds in the extract that stimulate proliferation of human hair keratinocytes. Clin. Exp. Dermatol. 2016,
41, 302–307. [CrossRef] [PubMed]
45. Roh, S.S.; Kim, C.D.; Lee, M.H.; Hwang, S.L.; Rang, M.J.; Yoon, Y.K. The hair growth promoting effect of
Sophora flavescens extract and its molecular regulation. J. Dermatol. Sci. 2002, 30, 43–49. [CrossRef]
46. Wikramanayake, T.C.; Villasante, A.C.; Mauro, L.M.; Perez, C.I.; Schachner, L.A.; Jimenez, J.J. Prevention and
treatment of alopecia areata with quercetin in the C3H/HeJ mouse model. Cell. Stress. Chaperones 2012, 17,
267–274. [CrossRef]
47. McElwee, K.J.; Niiyama, S.; Freyschmidt-Paul, P.; Wenzel, E.; Kissling, S.; Sundberg, J.P.; Hoffmann, R.
Dietary soy oil content and soy-derived phytoestrogen genistein increase resistance to alopecia areata onset
in C3H/HeJ mice. Exp. Dermatol. 2003, 12, 30–36. [CrossRef]
48. Yang, W.; Qiao, X.; Li, K.; Fan, J.; Bo, T.; Guo, D.A.; Ye, M. Identification and differentiation of Panax ginseng,
Panax quinquefolihum, and Panax notoginseng by monitoring multiple diagnostic chemical markers. Acta Pharm.
Sin. B. 2016, 6, 568–575. [CrossRef]
49. Yun, T.K. Brief introduction of Panax ginseng CA Meyer. J. Korean Med. Sci. 2001, 16, S3–S5. [CrossRef]
50. Takahashi, M.; Yoshikura, M.A.S.A. Studies on the components of Panax ginseng C.A. Meyer. V. On the
structure of a new acetylene derivative “Panaxynol” (3). Synthesis of 1,9-(cis)-heptadecadiene-4,6-diyn-3-ol].
Yakugaku Zasshi 1966, 86, 1053–1056. [CrossRef]
51. Majeed, F.; Malik, F.Z.; Ahmed, Z.; Afreen, A.; Afzal, M.N.; Khalid, N. Ginseng phytochemicals as therapeutics
in oncology: Recent perspectives. Biomed. Pharmacother. 2018, 100, 52–63. [CrossRef]
52. Li, J.J.; Gu, L.J.; Zhang, D.L.; Wang, Y.B.; Sung, C.K. Ginsenosides Rb1 and Rd regulate proliferation of
mature keratinocytes through induction of p63 expression in hair follicles. Phytother. Res. 2013, 27, 1095–1101.
[CrossRef]
53. Park, G.H.; Park, K.Y.; Cho, H.I.; Lee, S.M.; Han, J.S.; Won, C.H.; Chang, S.E.; Lee, M.W.; Choi, J.H.;
Moon, K.C.; et al. Red ginseng extract promotes the hair growth in cultured human hair follicles. J. Med.
Food. 2015, 18, 354–362. [CrossRef]
54. Kim, S.N.; Kim, S.; Hong, Y.D.; Park, H.; Shin, S.H.; Kim, A.R.; Park, B.C.; Shin, S.S.; Park, J.S.; Park, M.; et al.
The ginsenosides of Panax ginseng promote hair growth via similar mechanism of minoxidil. J. Dermatol. Sci.
2015, 77, 132–134. [CrossRef]
55. Bak, M.J.; Hong, S.; Lee, J.W.; Jeong, W.S. Red ginseng marc oil inhibits iNOS and COX-2 via NFκB and p38
pathways in LPS-stimulated RAW 264.7 macrophages. Molecules 2012, 17, 13769–13786. [CrossRef]
56. Truong, V.L.; Bak, M.J.; Lee, C.; Jun, M.; Jeong, W.S. Hair Regenerative Mechanisms of Red Ginseng Oil and
Its Major Components in the Testosterone-Induced Delay of Anagen Entry in C57BL/6 Mice. Molecules 2017,
8, 1505. [CrossRef]
57. Foitzik, K.; Lindner, G.; Mueller-Roever, S.; Maurer, M.; Botchkareva, N.; Botchkarev, V.; Handjiski, B.;
Metz, M.; Hibino, T.; Soma, T.; et al. Control of murine hair follicle regression (catagen) by TGF-beta1 in vivo.
FASEB J. 2000, 14, 752–760. [CrossRef]
Int. J. Mol. Sci. 2020, 21, 523 14 of 17
58. Matsuda, H.; Yamazaki, M.; Asanuma, Y.; Kubo, M. Promotion of hair growth by ginseng radix on cultured
mouse vibrissal hair follicles. Phytother. Res. 2003, 17, 797–800. [CrossRef]
59. Ryu, H.J.; Yoo, M.G.; Son, S.W. The efficacy of 3% minoxidil vs. combined 3% minoxidil and Korean red
ginseng in treating female pattern alopecia. Int. J. Dermatol 2014, 53, e340–e342. [CrossRef]
60. Li, Z.; Ryu, S.W.; Lee, J.; Choi, K.; Kim, S.; Choi, C. Protopanaxatirol type ginsenoside Re promotes cyclic
growth of hair follicles via inhibiting transforming growth factor β signaling cascades. Biochem. Biophys.
Res. Commun. 2016, 470, 924–929. [CrossRef]
61. Shin, H.S.; Park, S.Y.; Hwang, E.S.; Lee, D.G.; Song, H.G.; Mavlonov, G.T.; Yi, T.H. The inductive effect of
ginsenoside F2 on hair growth by altering the WNT signal pathway in telogen mouse skin. Eur. J. Pharmacol.
2014, 730, 82–89. [CrossRef]
62. Keum, D.I.; Pi, L.Q.; Hwang, S.T.; Lee, W.S. Protective effect of Korean Red Ginseng against chemotherapeutic
drug-induced premature catagen development assessed with human hair follicle organ culture model.
J. Ginseng. Res. 2016, 40, 169–175. [CrossRef]
63. Lee, Y.; Kim, S.N.; Hong, Y.D.; Park, B.C.; Na, Y. Panax ginseng extract antagonizes the effect of DKK-1-induced
catagen-like changes of hair follicles. Int. J. Mol. Med. 2017, 40, 1194–1200. [CrossRef]
64. Tenore, G.C.; Caruso, D.; Buonomo, G.; D’Urso, E.; D’Avino, M.; Campiglia, P.; Marinelli, L.; Novellino, E.
Annurca (Malus pumila Miller cv. Annurca) apple as a functional food for the contribution to a healthy
balance of plasma cholesterol levels: Results of a randomized clinical trial. J. Sci. Food Agric. 2017, 97,
2107–2115. [CrossRef]
65. Lu, B.; Sen, G.; Qingchao, L.; Xueqin, C.; Xinxin, Z.; Li, Z.; Xinwen, Y.; Manwei, H.; Chi-Tang, H.;
Naisheng, B. Characterization of nine polyphenols in fruits of Malus pumila Mill by high-performance liquid
chromatography. J. Food Drug Anal. 2016, 2, 293–298.
66. Tenore, G.C.; Caruso, D.; Buonomo, G.; D’Avino, M.; Santamaria, R.; Irace, C.; Piccolo, M.; Maisto, M.;
Novellino, E. Annurca Apple Nutraceutical Formulation Enhances Keratin Expression in a Human Model of
Skin and Promotes Hair Growth and Tropism in a Randomized Clinical Trial. J. Med. Food 2018, 21, 90–103.
[CrossRef]
67. Badolati, N.; Sommella, E.; Riccio, G.; Salviati, E.; Heintz, D.; Bottone, S.; Di Cicco, E.; Dentice, M.; Tenore, G.;
Campiglia, P.; et al. Annurca Apple Polyphenols Ignite Keratin Production in Hair Follicles by Inhibiting the
Pentose Phosphate Pathway and Amino Acid Oxidation. Nutrients 2018, 10, 1406. [CrossRef]
68. Riccio, G.; Sommella, E.; Badolati, N.; Salviati, E.; Bottone, S.; Campiglia, P.; Dentice, M.; Tenore, G.C.;
Stornaiuolo, M.; Novellino, E. Annurca Apple Polyphenols Protect Murine Hair Follicles from Taxane
Induced Dystrophy and Hijacks Polyunsaturated Fatty Acid Metabolism toward β-Oxidation. Nutrients
2018, 10, 1808. [CrossRef]
69. Majewski, M. Allium sativum: Facts and myths regarding human health. Rocz. Panstw. Zakl. Hig. 2014, 65,
1–8.
70. Ejaz, L.C.; Woong, A. Extract of garlic (Allium Sativum) in cancer chemopreventions. Exp. Oncol. 2003, 25,
93–97.
71. Suleria, H.A.R.; Butt, M.S.; Khalid, N.; Sultan, S.; Raza, A.; Aleem, M.; Abbas, M. Garlic (Allium sativum):
Diet based therapy of 21st centurya review. Asian. Pac. J. Trop. Dis. 2015, 5, 271–278. [CrossRef]
72. Ali, M.; Thomson, M.; Afzal, M. Garlic and onions: Their effect on eicosanoid metabolism and its clinical
relevance. Prostaglandins Leukot. Essent. Fat. Acids 2000, 62, 55–73. [CrossRef]
73. Ichikawa, M.; Yoshida, J.; Ide, N.; Sasaoka, T.; Yamaguchi, H.; Ono, K. Tetrahydro-beta-carboline derivatives
in aged garlic extract show antioxidant properties. J. Nutr. 2006, 136, 726S–731S. [CrossRef]
74. Jung, E.M.; Jung, F.; Mrowietz, C.; Kiesewetter, H.; Pindur, G.; Wenzel, E. Influence of garlic powder on
cutaneous microcirculation. A randomized placebo-controlled double-blind cross-over study in apparently
healthy subjects. Arzneimittelforschung 1991, 41, 626–630.
75. Kim, H. Protective Effect of Garlic on Cellular Senescence in UVB-Exposed HaCaT Human Keratinocytes.
Nutrients 2016, 8, 464. [CrossRef]
76. Homan, D.J.; Mobarhan, S. Coffee: Good, bad, or just fun? A critical review of coffee’s effects on liver
enzymes. Nutr. Rev. 2006, 64, 43–46. [CrossRef]
77. Hajheydari, Z.; Jamshidi, M.; Akbari, J.; Mohammadpour, R. Combination of topical garlic gel and
betamethasone valerate cream in the treatment of localized alopecia areata: A double-blind randomized
controlled study. Indian J. Dermatol. Venereol. Leprol. 2007, 73, 29–32. [CrossRef]
Int. J. Mol. Sci. 2020, 21, 523 15 of 17
78. Mehari, B.; Redi-Abshiro, M.; Chandravanshi, B.S.; Combrinck, S.; McCrindle, R.; Atlabachew, M. GC-MS
profiling of fatty acids in green coffee (Coffea arabica L.) beans and chemometric modeling for tracing
geographical origins from Ethiopia. J. Sci. Food. Agric. 2019, 99, 3811–3823. [CrossRef]
79. Fischer, T.W.; Herczeg-Lisztes, E.; Funk, W.; Zillikens, D.; Bíró, T.; Paus, R. Differential effects of caffeine
on hair shaft elongation, matrix and outer root sheath keratinocyte proliferation, and transforming growth
factor-β2/insulin-like growth factor-1-mediated regulation of the hair cycle in male and female human hair
follicles in vitro. Br. J. Dermatol. 2014, 171, 1031–1043.
80. Fischer, T.W.; Hipler, U.C.; Elsner, P. Effect of caffeine and testosterone on the proliferation of human hair
follicles in vitro. Int. J. Dermatol. 2007, 46, 27–35. [CrossRef]
81. Dhurat, R.; Chitallia, J.; May, T.W.; Jayaraaman, A.M.; Madhukara, J.; Anandan, S.; Vaidya, P.; Klenk, A.
An Open-Label Randomized Multicenter Study Assessing the Noninferiority of a Caffeine-Based Topical
Liquid 0.2% versus Minoxidil 5% Solution in Male Androgenetic Alopecia. Skin Pharmacol. Physiol. 2017, 30,
298–305. [CrossRef] [PubMed]
82. Bussoletti, C.; Tolaini, M.V.; Celleno, L. Efficacy of a cosmetic phyto-caffeine shampoo in female androgenetic
alopecia. G. Ital. Dermatol. Venereol. 2018. [CrossRef]
83. Miyoshi, N.; Pervin, M.; Suzuki, T.; Isemura, M.; Nakamura, Y. Green tea catechins for well-being and
therapy: Prospects and opportunities. Bot. Targets Ther. 2015, 5, 85–89.
84. Mondal, T.K.; Satya, P.; Medda, P.S. India needs national tea germplasm repository. In Proceedings of the
International Conference on Global Advances in Tea Science, Calcutta, India; 2003; pp. 58–59.
85. Rasouli, H.; Hosseini-Ghazvini, S.M.; Adibi, H.; Khodarahmi, R. Differential α-amylase/α-glucosidase
inhibitory activities of plant-derived phenolic compounds: A virtual screening perspective for the treatment
of obesity and diabetes. Food. Funct. 2017, 8, 1942–1954. [CrossRef] [PubMed]
86. Chen, F.C.; Shen, K.P.; Ke, L.Y.; Lin, H.L.; Wu, C.C.; Shaw, S.Y. Flavonoids from Camellia sinensis (L.) O.
Kuntze seed ameliorates TNF-α induced insulin resistance in HepG2 cells. Saudi Pharm. J. 2019, 27, 507–516.
[CrossRef] [PubMed]
87. Karimi, A.; Moradi, M.T.; Alidadi, S.; Hashemi, L. Anti-adenovirus Activity, Antioxidant Potential,
and Phenolic Content of Black Tea (Camellia Sinensis Kuntze) Extract. J. Complement Integr. Med. 2016, 13,
357–363. [CrossRef]
88. Wang, Y.C.; Bachrach, U. The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG).
Amino Acids 2003, 22, 131–143. [CrossRef]
89. Hsu, S.; Dickinson, D.; Borke, J.; Walsh, D.S.; Wood, J.; Qin, H.; Winger, J.; Pearl, H.; Schuster, G.; Bollag, W.B.
Green tea polyphenol induces caspase 14 in epidermal keratinocytes via MAPK pathways and reduces
psoriasiform lesions in the flaky skin mouse model. Exp. Dermatol. 2007, 16, 678–684. [CrossRef]
90. Hiipakka, R.A.; Zhang, H.Z.; Dai, W.; Dai, Q.; Liao, S. Structure-activity relationships for inhibition of human
5alpha-reductases by polyphenols. Biochem. Pharmacol. 2002, 63, 1165–1176. [CrossRef]
91. Kwon, O.S.; Han, J.H.; Yoo, H.G.; Chung, J.H.; Cho, K.H.; Eun, H.C.; Kim, K.H. Human hair growth
enhancement in vitro by green tea epigallocatechin-3-gallate (EGCG). Phytomedicine 2007, 14, 551–555.
[CrossRef]
92. Borges, R.S.; Ortiz, B.L.S.; Pereira, A.C.M.; Keita, H.; Carvalho, J.C.T. Rosmarinus officinalis essential
oil: A review of its phytochemistry, anti-inflammatory activity, and mechanisms of action involved.
J. Ethnopharmacol. 2019, 229, 29–45. [CrossRef] [PubMed]
93. Sebranek, J.G.; Sewalt, V.G.; Robbins, K.L.; Houser, T.A. Comparison of a natural rosemary extract and
BHA/BHT for relative antioxidant effectiveness in pork sausage. Meat Sci. 2005, 69, 289–296. [CrossRef]
[PubMed]
94. Moreno, S.; Scheyer, T.; Romano, C.S.; Vojnov, A.A. Antioxidant and antimicrobial activities of rosemary
extracts linked to their polyphenol composition. Free Radic. Res. 2006, 40, 223–231. [CrossRef] [PubMed]
95. Klancˇnik, A.; Guzej, B.; Kolar, M.H.; Abramovicˇ, H.; MOŽINA, S.S. In vitro antimicrobial and antioxidant
activity of commercial rosemary extract formulations. J. Food Prot. 2009, 72, 1744–1752.
96. Birtic´, S.; Dussort, P.; Pierre, F.X.; Bily, A.C.; Roller, M. Carnosic acid. Phytochemistry 2015, 115, 9–19.
[CrossRef]
97. Panahi, Y.; Taghizadeh, M.; Marzony, E.T.; Sahebkar, A. Rosemary oil vs. minoxidil 2% for the treatment of
androgenetic alopecia: A randomized comparative trial. Skinmed 2015, 13, 15–21.
Int. J. Mol. Sci. 2020, 21, 523 16 of 17
98. Borrás-Linares, I.; Stojanovic, Z.; Quirantes-Piné, R.; Arráez-Román, D.; Svarc-Gajié, J.;
Fernández-Gutiérrez, A.; Segura-Carretero, A.; Borrás-Linares, I.; Stojanovic´, Z. Rosmarinus officinalis
leaves as a natural source of bioactive compounds. Int. J. Mol. Sci. 2014, 15, 20585–20606. [CrossRef]
99. Murata, K.; Noguchi, K.; Kondo, M.; Onishi, M.; Watanabe, N.; Okamura, K.; Matsuda, H. Promotion of hair
growth by Rosmarinus officinalis leaf extract. Phytother. Res. 2013, 27, 212–217. [CrossRef]
100. Meghvansi, M.K.; Siddiqui, S.; Khan, M.H.; Gupta, V.K.; Vairale, M.G.; Gogoi, H.K.; Singh, L. Naga
chilli: A potential source of capsaicinoids with broad-spectrum ethnopharmacological applications. J.
Ethnopharmacol. 2010, 132, 1–14. [CrossRef]
101. Cirino, L.M.; Vergne, D.M.; Santana, P.F.; Almeida, E.D.; Costa, L.P.; Albuquerque-Júnior, R.L.; Lima-Verde, I.B.;
Padilha, F.F.; Cardoso, J.C. Decreased inflammatory response in rat bladder after intravesical administration
of capsaicin-loaded liposomes. An. Acad. Bras. Cienc. 2016, 88, 1539–1547. [CrossRef]
102. Bae, H.; Jayaprakasha, G.K.; Crosby, K.; Jifon, J.L.; Patil, B.S. Influence of extraction solvents on antioxidant
activity and the content of bioactive compounds in non-pungent peppers. Plant Foods Hum. Nutr. 2012, 67,
120–128. [CrossRef] [PubMed]
103. Pandey, K.B.; Rizvi, S.I. Plant polyphenols as dietary antioxidants in human health and disease. Oxid. Med.
Cell. Longev. 2009, 2, 270–278. [CrossRef] [PubMed]
104. Rastegar, H.; Ahmadi Ashtiani, H.; Aghaei, M.; Ehsani, A.; Barikbin, B. Combination of herbal extracts
and platelet-rich plasma induced dermal papilla cell proliferation: Involvement of ERK and Akt pathways.
J. Cosmet. Dermatol. 2013, 12, 116–122. [CrossRef] [PubMed]
105. Harada, N.; Okajima, K. Effects of capsaicin and isoflavone on blood pressure and serum levels of insulin-like
growth factor-I in normotensive and hypertensive volunteers with alopecia. Biosci. Biotechnol. Biochem. 2009,
73, 1456–1459. [CrossRef]
106. Parisi, O.I.; Scrivano, L.; Amone, F.; Malivindi, R.; Ruffo, M.; Vattimo, A.F.; Pezzi, V.; Puoci, F. Interconnected
PolymerS TeChnology (IPSTiC): An Effective Approach for the Modulation of 5α-Reductase Activity in Hair
Loss Conditions. J. Funct. Biomater. 2018, 9, 44. [CrossRef]
107. Paus, R.; Heinzelmann, T.; Schultz, K.D.; Furkert, J.; Fechner, K.; Czarnetzki, B.M. Hair growth induction by
substance P. Lab. Investig. 1994, 71, 134–140.
108. Ito, T.; Ito, N.; Saathoff, M.; Bettermann, A.; Takigawa, M.; Paus, R. Interferon-gamma Is a Potent Inducer
of Catagen-Like Changes in Cultured Human Anagen Hair Follicles. Br. J. Dermatol. 2005, 152, 623–631.
[CrossRef]
109. Lolli, F.; Pallotti, F.; Rossi, A.; Fortuna, M.C.; Caro, G.; Lenzi, A.; Sansone, A.; Lombardo, F. Androgenetic
alopecia: A review. Endocrine 2017, 57, 9–17. [CrossRef]
110. Spindler-Barth, M.; Schmidt, H.; Drews, U.; Spindler, K. Increase in activity of acetylcholinesterase by
20-OH-ecdysone in a Chironomus tentans cell line. Roux’s Arch. Dev. Biol. 1988, 197, 366–369. [CrossRef]
111. Wu, S.Z.; Wang, S.; Ratnaparkhi, R.; Bergfeld, W.F. Treatment of Pediatric Alopecia Areata with Anthralin:
A Retrospective Study of 37 Patients. Pediatr. Dermatol. 2018, 35, 817–820. [CrossRef]
112. McClellan, K.J.; Markham, A. Finasteride: A review of its use in male pattern hair loss. Drugs 1999, 57,
111–126. [CrossRef] [PubMed]
113. Gupta, A.K.; Charrette, A. The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia:
A network meta-analysis and benefit-risk assessment of finasteride and dutasteride. J. Dermatol. Treat. 2014,
25, 156–161. [CrossRef] [PubMed]
114. Blumeyer, A.; Tosti, A.; Messenger, A.; Reygagne, P.; Del Marmol, V.; Spuls, P.I.; Trakatelli, M.; Finner, A.;
Kiesewetter, F.; Trüeb, R.; et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia
in women and in men. Eur. Dermatol. Forum (EDF) J. Dtsch. Dermatol. Ges. 2011, 9 (Suppl. 6), S1–S57.
[CrossRef] [PubMed]
115. Beach Renée, A. Case series of oral minoxidil for androgenetic and traction alopecia: Tolerability & the five
C’s of oral therapy. Dermatol. Ther. 2018, 31, e12707.
116. Kanti, V.; Messenger, A.; Dobos, G.; Reygagne, P.; Finner, A.; Blumeyer, A.; Trakatelli, M.; Tosti, A.; Del
Marmol, V.; Piraccini, B.M.; et al. Evidence-based (S3) Guideline for the Treatment of Androgenetic Alopecia
in Women and in Men—Short Version. Eur. Acad. Dermatol. Venereol. 2018, 32, 11–22. [CrossRef]
117. Famenini, S.; Goh, C. Evidence for supplemental treatments in androgenetic alopecia. J. Drugs Dermatol.
2014, 13, 809–812.
Int. J. Mol. Sci. 2020, 21, 523 17 of 17
118. Lourith, N.; Kanlayavattanakul, M. Hair loss and herbs for treatment. J. Cosmet. Dermatol. 2013, 12, 210–222.
[CrossRef]
119. Patel, S.; Sharma, V.; Chauhan, N.S.; Thakur, M.; Dixit, V.K. Hair Growth: Focus on Herbal Therapeutic
Agent. Curr. Drug. Discov. Technol. 2015, 12, 21–42. [CrossRef]
120. Gentile, P.; Cole, J.P.; Cole, M.A.; Garcovich, S.; Bielli, A.; Scioli, M.G.; Orlandi, A.; Insalaco, C.; Cervelli, V.
Evaluation of Not-Activated and Activated PRP in Hair Loss Treatment: Role of Growth Factor and Cytokine
Concentrations Obtained by Different Collection Systems. Int. J. Mol. Sci. 2018, 18, 408. [CrossRef]
121. Gentile, P. Autologous Cellular Method Using Micrografts of Human Adipose Tissue Derived Follicle Stem
Cells in Androgenic Alopecia. Int. J. Mol. Sci. 2019, 20, 3446. [CrossRef]
122. Kang, J.I.; Kim, M.K.; Lee, J.H.; Jeon, Y.J.; Hwang, E.K.; Koh, Y.S.; Hyun, J.W.; Kwon, S.Y.; Yoo, E.S.; Kang, H.K.
Undariopsis peterseniana Promotes Hair Growth by the Activation of Wnt/β-Catenin and ERK Pathways.
Mar. Drugs 2017, 15, 130. [CrossRef] [PubMed]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
